Allianz Asset Management GmbH Invests $7.85 Million in Cognex Corporation $CGNX

Key Points

• Allianz Asset Management initiated a $7.85 million position in Cognex, buying 108,390 shares, while institutional investors collectively own 88.12% of the company.
• Cognex exceeded quarterly earnings expectations with EPS of $0.45 versus $0.42 forecast, and revenue rose 16.9% year over year to $291.26 million. The company issued fiscal 2026 EPS guidance of $1.64–$1.68.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $75.64, compared with a recent share price of $62.23. Cognex also pays a quarterly dividend of $0.085 per share, yielding approximately 0.5%.

Allianz Asset Management GmbH bought a new position in Cognex Corporation (NASDAQ:CGNX - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 108,390 shares of the scientific and technical instruments company's stock, valued at approximately $7,850,000. Allianz Asset Management GmbH owned about 0.06% of Cognex as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of CGNX. Royal Bank of Canada increased its stake in Cognex by 13.2% during the first quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company's stock worth $5,976,000 after acquiring an additional 23,326 shares during the last quarter. Empowered Funds LLC acquired a new position in shares of Cognex in the 1st quarter valued at about $291,000. Intech Investment Management LLC lifted its stake in shares of Cognex by 24.1% in the 1st quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company's stock valued at $1,415,000 after purchasing an additional 9,223 shares in the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock worth $27,000 after purchasing an additional 736 shares during the period. Finally, Cetera Investment Advisers grew its holdings in shares of Cognex by 7.5% during the 2nd quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company's stock worth $419,000 after purchasing an additional 920 shares during the period. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Cognex Stock Performance

Shares of NASDAQ:CGNX opened at $62.23 on Wednesday. The business's 50-day simple moving average is $63.62 and its 200 day simple moving average is $59.93. The company has a market cap of $10.47 billion, a P/E ratio of 60.42 and a beta of 1.49. Cognex Corporation has a one year low of $34.60 and a one year high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. The firm had revenue of $291.26 million during the quarter, compared to analysts' expectations of $292.10 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%.Cognex's quarterly revenue was up 16.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Analysts predict that Cognex Corporation will post 1.68 earnings per share for the current year.

Cognex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Thursday, August 20th were issued a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, August 20th. Cognex's dividend payout ratio (DPR) is presently 33.01%.

Wall Street Analyst Weigh In

Several research analysts recently commented on CGNX shares. DA Davidson set a $65.00 price target on shares of Cognex and gave the company a "neutral" rating in a report on Monday, August 10th. Truist Financial boosted their price objective on shares of Cognex from $71.00 to $78.00 and gave the stock a "hold" rating in a research note on Friday, August 7th. The Goldman Sachs Group reissued a "buy" rating and issued a $91.00 price objective on shares of Cognex in a research report on Friday, August 7th. Needham & Company LLC raised their target price on shares of Cognex from $75.00 to $80.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Finally, Weiss Ratings upgraded shares of Cognex from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Cognex presently has an average rating of "Moderate Buy" and a consensus target price of $75.64.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.